Dolca Thomas

Dolca Thomas, MD, is a seasoned immunologist and transplant nephrologist with a robust background in drug development and leadership. They currently serve as Chief Executive Officer of a Stealth Startup Biotech since 2023, having previously held prominent roles including Executive Vice President and Chief Medical Officer at Equillium, Inc., and Chief Medical Officer at Principia Biopharma. Dolca is also actively involved as a board member for several organizations, including UCB and Allakos Inc., and participates in advisory capacities at Ventus Therapeutics and AnaptysBio. They earned their MD from Weill Cornell Medical College and have completed fellowships in Internal Medicine, Nephrology, and Transplantation.